West Oak Capital’s Idexx Laboratories IDXX Stock Holding History

West Oak Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-35	Closed	-$11K	–	303
2022 Q3	$11K	Hold	35	–	–	0.01%	234
2022 Q2	$12K	Hold	35	–	–	0.01%	234
2022 Q1	$19K	Hold	35	–	–	0.01%	220
2021 Q4	$23K	Hold	35	–	–	0.01%	222
2021 Q3	$22K	Hold	35	–	–	0.01%	236
2021 Q2	$22K	Sell	35 -15	-30%	-$8.28K	0.01%	231
2021 Q1	$24K	Sell	50 -25	-33%	-$12.5K	0.01%	219
2020 Q4	$37K	Hold	75	–	–	0.02%	194
2020 Q3	$29K	Hold	75	–	–	0.02%	183
2020 Q2	$25K	Hold	75	–	–	0.01%	194
2020 Q1	$18K	Hold	75	–	–	0.01%	198
2019 Q4	$20K	Hold	75	–	–	0.01%	207
2019 Q3	$20K	Hold	75	–	–	0.01%	212
2019 Q2	$21K	Hold	75	–	–	0.01%	223
2019 Q1	$17K	Hold	75	–	–	0.01%	223
2018 Q4	$14K	Sell	75 -135	-64%	-$27.7K	0.01%	228
2018 Q3	$52.4K	Sell	210 -25	-11%	-$6.07K	0.03%	178
2018 Q2	$51.2K	Hold	235	–	–	0.03%	176
2018 Q1	$45K	Hold	235	–	–	0.03%	189
2017 Q4	$36.7K	Hold	235	–	–	0.02%	184
2017 Q3	$36.5K	Sell	235 -50	-18%	-$7.91K	0.02%	203
2017 Q2	$46K	Hold	285	–	–	0.03%	194
2017 Q1	$44.1K	Buy	285 +35	+14%	+$4.83K	0.03%	191
2016 Q4	$29.3K	Buy	+250	New	+$28.5K	0.02%	220

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

West Oak Capital's IDXX Position: Q4 2022 in Review

West Oak Capital sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 35 shares — an estimated $11K sold.

West Oak Capital first reported a position in IDXX in Q4 2016 and held it in 24 quarters. The position peaked at $52.4K in Q3 2018. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

West Oak Capital reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
West Oak Capital sold 35 Idexx Laboratories shares in Q4 2022, an estimated $11K.
West Oak Capital first reported a position in Idexx Laboratories in Q4 2016 and held it in 24 quarters.
West Oak Capital's Idexx Laboratories position peaked at $52.4K in Q3 2018.
999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on West Oak Capital's 13F filing for Q4 2022, filed 5 Jan 2023.